Works by Rhoda Molife, L.

Results: 14
    1
    2
    3

    First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 4, p. 406, doi. 10.1093/jjco/hyae182
    By:
    • Chung, Hsiao-Jen;
    • Kondoh, Chihiro;
    • Bae, Woo Kyun;
    • Tamada, Satoshi;
    • Matsubara, Nobuaki;
    • Lee, Hyo Jin;
    • Mizuno, Ryuichi;
    • Anai, Satoshi;
    • Kimura, Go;
    • Tomita, Yoshihiko;
    • Chang, Chao-Hsiang;
    • Chang, John Wen-Cheng;
    • Lin, Jianxin;
    • Perini, Rodolfo F;
    • Molife, L Rhoda;
    • Powles, Thomas;
    • Rini, Brian I;
    • Uemura, Hirotsugu
    Publication type:
    Article
    4

    Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours.

    Published in:
    2020
    By:
    • Kristeleit, Rebecca;
    • Evans, Jeffry;
    • Molife, L. Rhoda;
    • Tunariu, Nina;
    • Shaw, Heather;
    • Slater, Sarah;
    • Haris, Noor R. Md;
    • Brown, Nicholas F.;
    • Forster, Martin D.;
    • Diamantis, Nikolaos;
    • Rulach, Robert;
    • Greystoke, Alastair;
    • Asghar, Uzma;
    • Rata, Mihaela;
    • Anderson, Stephanie;
    • Bachmann, Felix;
    • Hannah, Alison;
    • Kaindl, Thomas;
    • Lane, Heidi A.;
    • Larger, Patrice J.
    Publication type:
    journal article
    5
    6

    Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.

    Published in:
    2018
    By:
    • Plummer, Ruth;
    • Verheul, Henk M.;
    • De Vos, Filip Y. F. L.;
    • Leunen, Karin;
    • Molife, L. Rhoda;
    • Rolfo, Christian;
    • Grundtvig-Sørensen, Peter;
    • De Grève, Jacques;
    • Rottey, Sylvie;
    • Jerusalem, Guy;
    • Italiano, Antoine;
    • Spicer, James;
    • Dirix, Luc;
    • Goessl, Carsten;
    • Birkett, Joseph;
    • Spencer, Stuart;
    • Learoyd, Maria;
    • Bailey, Christopher;
    • Dean, Emma
    Publication type:
    journal article
    7

    Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.

    Published in:
    Journal of Pathology, 2013, v. 229, n. 3, p. 422, doi. 10.1002/path.4140
    By:
    • Barber, Louise J;
    • Sandhu, Shahneen;
    • Chen, Lina;
    • Campbell, James;
    • Kozarewa, Iwanka;
    • Fenwick, Kerry;
    • Assiotis, Ioannis;
    • Rodrigues, Daniel Nava;
    • Reis-Filho, Jorge S;
    • Moreno, Victor;
    • Mateo, Joaquin;
    • Molife, L Rhoda;
    • De Bono, Johann;
    • Kaye, Stan;
    • Lord, Christopher J;
    • Ashworth, Alan
    Publication type:
    Article
    8
    9
    10

    Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1213, doi. 10.1007/s00280-013-2286-7
    By:
    • Molife, L. Rhoda;
    • Rudman, Sarah M.;
    • Alam, Salma;
    • Tan, Daniel S.-W.;
    • Kristeleit, Hartmut;
    • Middleton, Gary;
    • Propper, David;
    • Bent, Liz;
    • Stopfer, Peter;
    • Uttenreuther-Fischer, Martina;
    • Wallenstein, Gudrun;
    • de Bono, Johann;
    • Spicer, James
    Publication type:
    Article
    11

    Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.

    Published in:
    British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1807, doi. 10.1111/bcp.14283
    By:
    • Rolfo, Christian;
    • Isambert, Nicolas;
    • Italiano, Antoine;
    • Molife, L. Rhoda;
    • Schellens, Jan H.M.;
    • Blay, Jean‐Yves;
    • Decaens, Thomas;
    • Kristeleit, Rebecca;
    • Rosmorduc, Olivier;
    • Demlova, Regina;
    • Lee, Myung‐Ah;
    • Ravaud, Alain;
    • Kopeckova, Katerina;
    • Learoyd, Maria;
    • Bannister, Wendy;
    • Locker, Gershon;
    • Vos‐Geelen, Judith
    Publication type:
    Article
    12
    13

    Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors.

    Published in:
    Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 3, doi. 10.1186/1756-8722-7-1
    By:
    • Rhoda Molife, L.;
    • Li Yan;
    • Vitfell-Rasmussen, Joanna;
    • Zernhelt, Adriane M.;
    • Sullivan, Daniel M.;
    • Cassier, Philippe A.;
    • Eric Chen;
    • Biondo, Andrea;
    • Tetteh, Ernestina;
    • Siu, Lillian L.;
    • Patnaik, Amita;
    • Papadopoulos, Kyriakos P.;
    • De Bono, Johann S.;
    • Tolcher, Anthony W.;
    • Minton, Susan
    Publication type:
    Article
    14

    Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.

    Published in:
    PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020
    By:
    • Perkins, Geraldine;
    • Yap, Timothy A.;
    • Pope, Lorna;
    • Cassidy, Amy M.;
    • Dukes, Juliet P.;
    • Riisnaes, Ruth;
    • Massard, Christophe;
    • Cassier, Philippe A.;
    • Miranda, Susana;
    • Clark, Jeremy;
    • Denholm, Katie A.;
    • Thway, Khin;
    • De Castro, David Gonzalez;
    • Attard, Gerhardt;
    • Molife, L. Rhoda;
    • Kaye, Stan B.;
    • Banerji, Udai;
    • de Bono, Johann S.
    Publication type:
    Article